Thermo Fisher Scientific response to COVID-19 expands to include serology test
Collaboration with WuXi Diagnostics and Mayo Clinic on serology test will complement Thermo Fisher's widely adopted TaqPath COVID-19 molecular diagnostic test
Collaboration with WuXi Diagnostics and Mayo Clinic on serology test will complement Thermo Fisher's widely adopted TaqPath COVID-19 molecular diagnostic test
The FDA has issued its fourth Emergency Use Authorization for coronavirus tests, this time to Thermo Fisher Scientific for its TaqPath COVID-19 Combo Kit
Ion Torrent CarrierSeq ECS Kit consolidates multi-testing approach into a single, end-to-end workflow to facilitate implementation globally
The ALPS 5000 is designed to alleviate the maintenance burden on operators, while offering unparalleled process customization capabilities
Thermo Fisher Scientific is exhibiting in booth #2110 at the Anaheim Convention Center, Anaheim, California, August 4–8
Thermo Fisher and Biognosys to develop industry-leading mass spectrometry-based workflows for the efficient analysis of proteins in complex biological matrices
New TaqMan & SYBR Green Fast Advanced Cells-to-CT Kits promise a faster and more sensitive way to measure gene expression
Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs
Oncomine Cell-Free DNA Assay is designed to target and detect mutations down to 0.1 percent allele frequencies from whole blood derived from lung cancer tumors
New software connects public health laboratories with MicrobeNet database to advance infectious disease surveillance